Halle C. F. Moore

Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer

Shanu Modi, William Jacot, Toshinari Yamashita et al. · New England Journal of Medicine · 2022 · 2.5K citations · Full text

Medicine, Oncology, Pharmacology +17

Goserelin for Ovarian Protection during Breast-Cancer Adjuvant Chemotherapy

Halle C. F. Moore, Joseph M. Unger, Kelly‐Anne Phillips et al. · New England Journal of Medicine · 2015 · 542 citations · Full text

Medicine, Gynecology, Oncology +16

Dietary Supplement Use During Chemotherapy and Survival Outcomes of Patients With Breast Cancer Enrolled in a Cooperative Group Clinical Trial (SWOG S0221)

Christine B. Ambrosone, Gary Zirpoli, Alan D. Hutson et al. · Journal of Clinical Oncology · 2019 · 234 citations · Full text

Medicine, Oncology, Pharmacology +14

Interrupting Endocrine Therapy to Attempt Pregnancy after Breast Cancer

Ann H. Partridge, Samuel M. Niman, Monica Ruggeri et al. · New England Journal of Medicine · 2023 · 215 citations · Full text

Medicine, Endocrinology, Oncology +17

Zoledronic Acid Effectively Prevents Aromatase Inhibitor–Associated Bone Loss in Postmenopausal Women with Early Breast Cancer Receiving Adjuvant Letrozole: Z-FAST Study 36-Month Follow-up Results

Adam Brufsky, Linda D. Bosserman, R. Caradonna et al. · Clinical Breast Cancer · 2009 · 214 citations

Medicine, Oncology, Pharmacology +14